For total disclosure, I have been genuinely interested in RAC but it has way less products in the pipeline than IMU, less operating cash, less in the clinic, less in development and has literally made zero progress, fundamentally, for years.
RAC’s share price has not been acting in the same way as other Biotech’s in the last week or so. I’m genuinely wondering why?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.025(2.11%) |
Mkt cap ! $201.5M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.19 | $1.16 | $39.17K | 33.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3560 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 4359 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |